Takeda Pharmaceutical (NYSE:TAK) Posts Earnings Results, Misses Estimates By $0.07 EPS
Takeda Pharmaceutical (NYSE:TAK - Get Free Report) posted its earnings results on Thursday. The company reported $0.48 earnings per share (EPS) for the quarter, missing analysts' consensus estimates...